{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T20:25:04Z","timestamp":1778358304293,"version":"3.51.4"},"reference-count":276,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.encep.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:58:26Z","timestamp":1630544306000},"page":"564-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychotropics and COVID-19: An analysis of safety and prophylaxis"],"prefix":"10.1016","volume":"47","author":[{"given":"H.","family":"Javelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Straczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gitahy Falcao Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Drapier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fakra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Langr\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hingray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Haffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Yrondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2021.08.002_bib1000","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.encep.2020.04.006","article-title":"Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic","volume":"46","author":"Javelot","year":"2020","journal-title":"Encephale"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12916-020-01685-9","article-title":"Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations","volume":"18","author":"Ostuzzi","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.encep.2021.08.002_bib1010","doi-asserted-by":"crossref","first-page":"110025","DOI":"10.1016\/j.mehy.2020.110025","article-title":"Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances","volume":"144","author":"Javelot","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.encep.2021.08.002_bib1015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11845-020-02346-9","article-title":"Psychoactive compounds as multifactorial protection factors against COVID-19","volume":"190","author":"Javelot","year":"2020","journal-title":"Ir J Med Sci"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: the reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"Encephale"},{"key":"10.1016\/j.encep.2021.08.002_bib1025","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.drudis.2020.06.022","article-title":"Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders","volume":"25","author":"Villoutreix","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.encep.2021.08.002_bib1030","doi-asserted-by":"crossref","first-page":"112902","DOI":"10.1016\/j.psychres.2020.112902","article-title":"The psychiatric impact of the novel coronavirus outbreak","volume":"286","author":"Carvalho","year":"2020","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib1040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.schres.2020.04.030","article-title":"Long-acting injectable antipsychotics treatment during COVID-19 pandemic\u00a0\u2013\u00a0A new challenge","volume":"220","author":"Ifteni","year":"2020","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1045","unstructured":"Oxford Precision Psychiatry Lab. COVID-19 & clinical management of mental health issues. Evidence-based guidance. https:\/\/oxfordhealthbrc.nihr.ac.uk\/our-work\/oxppl\/covid-19-and-mental-health-guidance\/."},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/ebmental-2020-300155","article-title":"Covid-19 and mental health: a transformational opportunity to apply an evidence-based approach to clinical practice and research","volume":"23","author":"Smith","year":"2020","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.encep.2021.08.002_bib1055","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.encep.2020.04.009","article-title":"Challenges for psychotropics in the context of the SARS-Cov-2 pandemic","volume":"46","author":"Javelot","year":"2020","journal-title":"Encephale"},{"issue":"S1","key":"10.1016\/j.encep.2021.08.002_bib1060","first-page":"159","article-title":"Psychopharmacotherapeutic guidelines: a challenge during health crisis","volume":"75","author":"Javelot","year":"2020","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.encep.2021.08.002_bib1065","doi-asserted-by":"crossref","first-page":"102071","DOI":"10.1016\/j.ajp.2020.102071","article-title":"Impact of COVID-19 pandemic on pre-existing mental health problems","volume":"51","author":"Chatterjee","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.encep.2021.08.002_bib1070","article-title":"A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. Preprint","author":"Gordon","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.encep.2021.08.002_bib1075","article-title":"Low prevalence of SARS-CoV-2 among patients presenting at a Parisian psychiatry University Hospital Group","author":"El-Khoury","year":"2020","journal-title":"Eur J Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.2020.20030348","article-title":"COVID-19, medication-assisted treatment, and increased risk for further respiratory depression","volume":"177","author":"Boyer","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1085","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/j.bja.2020.07.004","article-title":"Opioids and the COVID-19 pandemic: does chronic opioid use or misuse increase clinical vulnerability?","volume":"125","author":"Lambert","year":"2020","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S1041610220001015","article-title":"Old age psychiatry services in the UK responding to COVID-19","volume":"32","author":"Vedavanam","year":"2020","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.encep.2021.08.002_bib1100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/17476348.2019.1563486","article-title":"Mirtazapine for chronic breathlessness? A review of mechanistic insights and therapeutic potential","volume":"13","author":"Lowell","year":"2019","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/YIC.0000000000000248","article-title":"Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis","volume":"34","author":"Ostuzzi","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib1110","first-page":"CD012346","article-title":"Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease","volume":"12","author":"Pollok","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tcm.2017.07.010","article-title":"CredibleMeds.org: what does it offer?","volume":"28","author":"Woosley","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.encep.2021.08.002_bib1125","article-title":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)","author":"Chen","year":"2020","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1135","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/bcp.14335","article-title":"COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?","volume":"86","author":"Javelot","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/joa3.12393","article-title":"Risk of QTc prolongation with Chloroquine\/Hyroxychloroquine and Azithromycin treatment for COVID-19: quantification and precautions for a busy clinician","volume":"36","author":"Mansuri","year":"2020","journal-title":"J Arrhythm"},{"issue":"1145","key":"10.1016\/j.encep.2021.08.002_bib1145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/postgradmedj-2020-138093","article-title":"COVID-19 and the burning issue of drug interaction: never forget the ECG","volume":"97","author":"Sciaccaluga","year":"2020","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.respe.2016.06.335","article-title":"R\u00e9seau fran\u00e7ais des centres r\u00e9gionaux de pharmacovigilance. Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: case\/non-case analysis in the national pharmacovigilance database","volume":"65","author":"Rochoy","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.encep.2020.08.001","article-title":"Panic and pandemic: narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic","volume":"47","author":"Javelot","year":"2021","journal-title":"Encephale"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.psym.2020.05.006","article-title":"Psychopharmacology of COVID-19","volume":"61","author":"Bilbul","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2021.08.002_bib1165","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320935306","article-title":"Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents","volume":"10","author":"Bishara","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib1170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT prolongation, torsades de pointes, and psychotropic medication: a 5-year update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatic"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1192\/bjp.2020.84","article-title":"Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders","volume":"217","author":"Zhang","year":"2020","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/acps.13066","article-title":"Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies","volume":"140","author":"Papola","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"10.1016\/j.encep.2021.08.002_bib1185","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.encep.2021.08.002_bib1190","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00213-016-4266-1","article-title":"Is it time for immunopsychiatry in psychotic disorders?","volume":"233","author":"Leboyer","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1195","doi-asserted-by":"crossref","first-page":"e0218937","DOI":"10.1371\/journal.pone.0218937","article-title":"The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice","volume":"14","author":"May","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1200","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00223-2018","article-title":"Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia","volume":"5","author":"Boivin","year":"2019","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40266-020-00754-1","article-title":"Psychotropic drug-associated pneumonia in older adults","volume":"37","author":"Rajamaki","year":"2020","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.encep.2021.08.002_bib1210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269881118795333","article-title":"Antipsychotic drug use and pneumonia: systematic review and meta-analysis","volume":"32","author":"Dzahini","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/wps.20707","article-title":"Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics","volume":"19","author":"de Leon","year":"2020","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1220","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.4088\/JCP.12m07938","article-title":"Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study","volume":"74","author":"Yang","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1225","doi-asserted-by":"crossref","first-page":"e0187034","DOI":"10.1371\/journal.pone.0187034","article-title":"Biological substantiation of antipsychotic-associated pneumonia: systematic literature review and computational analyses","volume":"12","author":"Sultana","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11908-011-0175-y","article-title":"Antipsychotic drug use and community-acquired pneumonia","volume":"13","author":"Trifir\u00f2","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jgs.13327","article-title":"Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study","volume":"63","author":"Paul","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jgs.13932","article-title":"Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study","volume":"64","author":"Chatterjee","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.encep.2021.08.002_bib1245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","article-title":"Haematological toxicity of drugs used in psychiatry","volume":"23","author":"Flanagan","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11920-015-0603-z","article-title":"Management of adverse effects of mood stabilizers","volume":"17","author":"Murru","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.encep.2021.08.002_bib1255","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2019.02569","article-title":"Understanding infection-induced thrombosis: lessons learned from animal models","volume":"10","author":"Beristain-Covarrubias","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1260","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.21037\/apm.2020.04.05","article-title":"Viral infection related venous thromboembolism: potential mechanism and therapeutic targets","volume":"9","author":"Yu","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1270","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2020.1300","article-title":"COVID-19 and coagulative axis: review of emerging aspects in a novel disease","volume":"90","author":"Boccia","year":"2020","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.encep.2021.08.002_bib1275","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.7861\/clinmed.2020-0228","article-title":"Thrombotic risk in COVID-19: a case series and case-control study","author":"Stoneham","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"11","key":"10.1016\/j.encep.2021.08.002_bib1280","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40263-018-0495-7","article-title":"Venous thromboembolism during treatment with antipsychotics: a review of current evidence","volume":"32","author":"J\u00f6nsson","year":"2018","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pds.2210","article-title":"Antipsychotic drugs and risk of pulmonary embolism","volume":"21","author":"Allenet","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/07853890.2018.1500703","article-title":"Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence","volume":"50","author":"Kunutsor","year":"2018","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1300","first-page":"57","article-title":"Antidepressant use and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2019","journal-title":"J Pharm Sci"},{"issue":"Suppl 1","key":"10.1016\/j.encep.2021.08.002_bib1305","first-page":"19","article-title":"Deep venous thrombosis and pulmonary embolism in psychiatric setting","volume":"23","author":"Van Neste","year":"2009","journal-title":"Eur J Pyschiat"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1310","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/2045125315612334","article-title":"A review of the management of antidepressant discontinuation symptoms","volume":"5","author":"Wilson","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2019.052","article-title":"Stopping and switching antipsychotic drugs","volume":"42","author":"Keks","year":"2019","journal-title":"Aust Prescr"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neures.2010.08.009","article-title":"Withdrawal from methylphenidate increases neural reactivity of dorsal midbrain","volume":"68","author":"Ferreira","year":"2010","journal-title":"Neurosci Res"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1330","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother Psychosom"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1335","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","article-title":"Systematic review of anticholinergic risk scales in older adults","volume":"69","author":"Dur\u00e1n","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib1340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.encep.2021.08.002_bib1345","series-title":"StatPearls","article-title":"Sympathomimetics [Updated 2020 Jun 2]","author":"Horowitz","year":"2020"},{"key":"10.1016\/j.encep.2021.08.002_bib1350","doi-asserted-by":"crossref","first-page":"589884","DOI":"10.3389\/fpsyg.2020.589884","article-title":"How do Nocebo phenomena provide a theoretical framework for the COVID-19 pandemic?","volume":"11","author":"Amanzio","year":"2020","journal-title":"Front Psychol"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1355","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpsy.2020.10.004","article-title":"Are dopamine and serotonin involved in COVID-19 pathophysiology?","volume":"35","author":"Attademo","year":"2021","journal-title":"Eur J Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1360","doi-asserted-by":"crossref","first-page":"m3871","DOI":"10.1136\/bmj.m3871","article-title":"Neuropsychiatric complications of COVID-19","volume":"371","author":"Butler","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1365","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00406-020-01197-w","article-title":"The role of neurotropism in psychiatric patients with COVID-19","volume":"271","author":"Diaz","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib1370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbi.2020.06.020","article-title":"Spectrum of neuropsychiatric manifestations in COVID-19","volume":"88","author":"Nalleballe","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.encep.2021.08.002_bib1375","doi-asserted-by":"crossref","first-page":"110159","DOI":"10.1016\/j.pnpbp.2020.110159","article-title":"The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses","volume":"106","author":"de Sousa Moreira","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11481-020-09966-z","article-title":"Can cytokine blocking prevent depression in COVID-19 survivors?","volume":"16","author":"Benedetti","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib1385","doi-asserted-by":"crossref","first-page":"113137","DOI":"10.1016\/j.psychres.2020.113137","article-title":"Schizophrenia and COVID-19 delirium","volume":"290","author":"Palomar-Ciria","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1390","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.schres.2020.05.009","article-title":"Coronovirus infection as a novel delusional topic","volume":"222","author":"Ovejero","year":"2020","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1395","doi-asserted-by":"crossref","first-page":"113052","DOI":"10.1016\/j.psychres.2020.113052","article-title":"Psychosis in a patient with anxiety related to COVID-19: a case report","volume":"289","author":"Huarcaya-Victoria","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1400","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pcn.13107","article-title":"A case with psychotic disorder as a clinical presentation of COVID-19","author":"Majadas","year":"2020","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib1405","doi-asserted-by":"crossref","first-page":"113254","DOI":"10.1016\/j.psychres.2020.113254","article-title":"Psychotic symptoms in COVID-19 patients. A retrospective descriptive study","volume":"291","author":"Parra","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1410","doi-asserted-by":"crossref","first-page":"113097","DOI":"10.1016\/j.psychres.2020.113097","article-title":"New-onset psychosis in COVID-19 pandemic: a case series in Madrid","volume":"290","author":"Rentero","year":"2020","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1415","first-page":"20l02640","article-title":"Psychosis in patients in COVID-19-related quarantine: a case series","volume":"22","author":"Finatti","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib1420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.genhosppsych.2020.05.008","article-title":"Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement","volume":"65","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1425","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1430","doi-asserted-by":"crossref","first-page":"102188","DOI":"10.1016\/j.ajp.2020.102188","article-title":"Neuropsychiatric aspects of COVID-19 pandemic: a selective review","volume":"53","author":"Dinakaran","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.encep.2021.08.002_bib1435","doi-asserted-by":"crossref","first-page":"135491","DOI":"10.1016\/j.neulet.2020.135491","article-title":"COVID-19 and psychosis risk: real or delusional concern?","volume":"741","author":"Watson","year":"2021","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1440","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.psym.2020.05.012","article-title":"COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?","volume":"61","author":"Ferrando","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2021.08.002_bib1445","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.genhosppsych.2020.06.001","article-title":"COVID-19 treatment-induced neuropsychiatric adverse effects","volume":"67","author":"Garc\u00eda","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1450","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4088\/JCP.15l09920","article-title":"An open-label, pilot trial of adjunctive tocilizumab in schizophrenia","volume":"77","author":"Miller","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1455","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/0004867420940775","article-title":"Vulnerability of people with schizophrenia to COVID-19","volume":"54","author":"Maguire","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1460","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1590\/1516-4446-2020-0010","article-title":"Schizophrenia and COVID-19: risks and recommendations","volume":"42","author":"Fonseca","year":"2020","journal-title":"Braz J Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1465","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2020.05.013","article-title":"Neurocovid: pharmacological recommendations for delirium associated with COVID-19","volume":"61","author":"Baller","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2021.08.002_bib1470","article-title":"Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches. Ther","volume":"10","author":"Ostuzzi","year":"2020","journal-title":"Adv Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1475","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/ipm.2020.71","article-title":"Developing a guidance resource for managing delirium in patients with COVID-19","volume":"38","author":"Meagher","year":"2020","journal-title":"Ir J Psychol Med"},{"key":"10.1016\/j.encep.2021.08.002_bib1480","doi-asserted-by":"crossref","first-page":"100147","DOI":"10.1016\/j.bbih.2020.100147","article-title":"Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: lessons learned and recommendations","volume":"9","author":"Ojeahere","year":"2020","journal-title":"Brain Behav Immun Health"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1485","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5811\/westjem.2020.5.47789","article-title":"Management of agitation during the COVID-19 pandemic","volume":"21","author":"Wong","year":"2020","journal-title":"West J Emerg Med"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1490","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ageing\/afq140","article-title":"Which medications to avoid in people at risk of delirium: a systematic review","volume":"40","author":"Clegg","year":"2011","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1495","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamapsychiatry.2018.4365","article-title":"Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis","volume":"76","author":"Wu","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1500","doi-asserted-by":"crossref","first-page":"109985","DOI":"10.1016\/j.mehy.2020.109985","article-title":"Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects","volume":"144","author":"Fitzgerald","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.encep.2021.08.002_bib1505","doi-asserted-by":"crossref","first-page":"118063","DOI":"10.1016\/j.lfs.2020.118063","article-title":"Update on neurological manifestations of COVID-19","volume":"257","author":"Yavarpour-Bali","year":"2020","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1510","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/jmv.25826","article-title":"An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19","volume":"92","author":"Nataf","year":"2020","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1515","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.psym.2020.05.021","article-title":"A case of catatonia in a man with COVID-19","volume":"61","author":"Caan","year":"2020","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1520","first-page":"256","article-title":"Life-threatening catatonia associated with coronavirus disease 2019","volume":"62","author":"Deocleciano de Araujo","year":"2020","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1525","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/pcn.13174","article-title":"Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID-19: a case report","volume":"75","author":"Zandifar","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib1530","doi-asserted-by":"crossref","first-page":"110274","DOI":"10.1016\/j.mehy.2020.110274","article-title":"Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19","volume":"144","author":"Pomara","year":"2020","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1535","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.biopsych.2020.05.032","article-title":"Chloroquine-induced first-episode psychosis in a patient self-medicated for COVID-19","volume":"89","author":"Ambar Akkaoui","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1540","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620957141","article-title":"Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations","volume":"11","author":"Biswas","year":"2020","journal-title":"Ther Adv Drug Saf"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib1545","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40264-020-01013-3","article-title":"Psychiatric disorders and hydroxychloroquine for coronavirus disease 2019 (COVID-19): a VigiBase study","volume":"43","author":"Garcia","year":"2020","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1550","doi-asserted-by":"crossref","first-page":"20l13476","DOI":"10.4088\/JCP.20l13476","article-title":"Psychiatric side effects of chloroquine","volume":"81","author":"Gressier","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1555","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.psym.2020.06.022","article-title":"Psychiatric aspects of chloroquine and hydroxychloroquine treatment in the wake of coronavirus disease-2019: psychopharmacological interactions and neuropsychiatric sequelae","volume":"61","author":"Hamm","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2021.08.002_bib1560","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.ajp.2020.102203","article-title":"Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic","volume":"54","author":"Stip","year":"2020","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1565","article-title":"The risks of prescribing hydroxychloroquine in COVID-19-infected patients with schizophrenia","volume":"22","author":"Uvais","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1570","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.revmed.2012.12.011","article-title":"Troubles psychiatriques induits par la corticoth\u00e9rapie orale: mise au point sur la nature, l\u2019incidence, les facteurs de risque et le traitement","volume":"34","author":"Ricoux","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.encep.2021.08.002_bib1575","series-title":"AEMPS","year":"2020"},{"key":"10.1016\/j.encep.2021.08.002_bib1580","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1590","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psym.2020.05.025","article-title":"Clozapine toxicity in the setting of COVID-19","volume":"61","author":"Dotson","year":"2020","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1595","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjb.2020.66","article-title":"Clozapine and COVID-19","volume":"44","author":"Silva","year":"2020","journal-title":"BJPsych Bull"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1600","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/brainsci10020105","article-title":"Focus on clozapine withdrawal- and misuse-related cases as reported to the European Medicines Agency (EMA) pharmacovigilance database","volume":"10","author":"Chiappini","year":"2020","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1605","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/schbul\/sbr202","article-title":"Second-generation antipsychotic medications and risk of pneumonia in schizophrenia","volume":"39","author":"Kuo","year":"2013","journal-title":"Schizophr Bull"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1610","doi-asserted-by":"crossref","first-page":"450","DOI":"10.9758\/cpn.2020.18.3.450","article-title":"Clozapine in the time of COVID-19","volume":"18","author":"Boland","year":"2020","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib1615","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320959560","article-title":"Clozapine prescribing in COVID-19 positive medical inpatients: a case series","volume":"10","author":"Butler","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"issue":"11","key":"10.1016\/j.encep.2021.08.002_bib1620","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/brainsci10110840","article-title":"Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19","volume":"10","author":"Dragoi","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.encep.2021.08.002_bib1625","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320940935","article-title":"The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine","volume":"10","author":"Gee","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib1630","first-page":"1","article-title":"Clozapine treatment and risk of COVID-19 infection: retrospective cohort study","author":"Govind","year":"2020","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1635","article-title":"Death from COVID-19 in a patient receiving clozapine: factors involved and prevention strategies to consider","volume":"22","author":"Llesuy","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib1640","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.schres.2020.05.001","article-title":"Long acting injectable antipsychotic medications: ensuring care continuity during the COVID-19 pandemic restrictions","volume":"222","author":"Gannon","year":"2020","journal-title":"Schizophr Res"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1645","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0004867420927465","article-title":"Monitoring for post-injection delirium\/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic","volume":"54","author":"Siskind","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2021.08.002_bib1650","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2215-0366(20)30307-2","article-title":"How mental health care should change as a consequence of the COVID-19 pandemic","volume":"7","author":"Moreno","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1655","doi-asserted-by":"crossref","first-page":"e203976","DOI":"10.1001\/jamanetworkopen.2020.3976","article-title":"Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1660","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/ipm.2020.40","article-title":"Fallout from the COVID-19 pandemic\u00a0\u2013\u00a0should we prepare for a tsunami of post-viral depression?","volume":"37","author":"Lyons","year":"2020","journal-title":"Ir J Psychol Med"},{"key":"10.1016\/j.encep.2021.08.002_bib1665","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.encep.2021.08.002_bib1670","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.05.026","article-title":"Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"88","author":"Pappa","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1675","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jinf.2020.06.073","article-title":"Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?","volume":"81","author":"Batisse","year":"2020","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1680","first-page":"17","article-title":"Mood and cognitive changes during systemic corticosteroid therapy","volume":"3","author":"Brown","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1685","doi-asserted-by":"crossref","first-page":"113198","DOI":"10.1016\/j.psychres.2020.113198","article-title":"COVID-19, interferons, and depression: a commentary","volume":"291","author":"Shader","year":"2020","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1690","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1819.2011.02260.x","article-title":"Psychiatric complications of treatment with corticosteroids: review with case report","volume":"65","author":"Kenna","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1695","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1570159X14666160106155129","article-title":"Interferon-related depression: a primer on mechanisms, treatment, and prevention of a common clinical problem","volume":"14","author":"Pinto","year":"2016","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1700","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1705","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/YCT.0000000000000708","article-title":"ECT and COVID-19 in acute inpatient psychiatry: more than clinical issues alone","volume":"63","author":"Boland","year":"2020","journal-title":"J ECT"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1710","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/YCT.0000000000000702","article-title":"A strategy for management of ECT patients during the COVID-19 pandemic","volume":"36","author":"Bryson","year":"2020","journal-title":"J ECT"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1715","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jagp.2020.05.007","article-title":"Electroconvulsive therapy for geriatric depression in the COVID-19 era: reflection on the ethics","volume":"28","author":"Burhan","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1720","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/YCT.0000000000000688","article-title":"Images in clinical ECT: immediate impact of COVID-19 on ECT practice","volume":"36","author":"Colbert","year":"2020","journal-title":"J ECT"},{"key":"10.1016\/j.encep.2021.08.002_bib1725","doi-asserted-by":"crossref","first-page":"113057","DOI":"10.1016\/j.psychres.2020.113057","article-title":"Access barriers to electroconvulsive therapy during COVID-19 pandemic","volume":"289","author":"Daniel","year":"2020","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1730","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/YCT.0000000000000689","article-title":"Electroconvulsive therapy during COVID-19: an essential medical procedure-maintaining service viability and accessibility","volume":"36","author":"Espinoza","year":"2020","journal-title":"J ECT"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1735","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/YCT.0000000000000705","article-title":"General anesthesia recommendations for electroconvulsive therapy during the coronavirus disease 2019 pandemic","volume":"36","author":"Limoncelli","year":"2020","journal-title":"J ECT"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1740","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000509113","article-title":"Modified anesthesia protocol for electroconvulsive therapy permits reduction in aerosol-generating bag-mask ventilation during the COVID-19 pandemic","volume":"89","author":"Luccarelli","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1745","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jagp.2020.04.013","article-title":"Electroconvulsive therapy during COVID-19-times: our patients cannot wait","volume":"28","author":"Sienaert","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1750","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/YCT.0000000000000707","article-title":"Uninterrupted anesthesia support and technique adaptations for patients presenting for electroconvulsive therapy during the COVID-19 era","volume":"36","author":"Thiruvenkatarajan","year":"2020","journal-title":"J ECT"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1755","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.brs.2020.05.010","article-title":"Guidelines for TMS\/tES clinical services and research through the COVID-19 pandemic","volume":"13","author":"Bikson","year":"2020","journal-title":"Brain Stimul"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1760","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jagp.2020.04.024","article-title":"Remote monitoring of intranasal ketamine self-administration as maintenance therapy in treatment-resistant depression (TRD): a novel strategy for vulnerable and at-risk populations to COVID-19?","volume":"28","author":"Longpr\u00e9-Poirier","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1765","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1002\/jmv.26681","article-title":"Ketamine in COVID-19 patients: thinking out of the box","volume":"93","author":"Akinosoglou","year":"2021","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1770","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/da.23071","article-title":"COVID stress syndrome: concept, structure, and correlates","volume":"37","author":"Taylor","year":"2020","journal-title":"Depress Anxiety"},{"issue":"22","key":"10.1016\/j.encep.2021.08.002_bib1775","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","article-title":"Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up","volume":"169","author":"Lam","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib1780","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"WFSBP task force on mental disorders in primary care; WFSBP Task Force on Anxiety disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.encep.2021.08.002_bib1785","doi-asserted-by":"crossref","first-page":"112921","DOI":"10.1016\/j.psychres.2020.112921","article-title":"Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter","volume":"287","author":"Liu","year":"2020","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1790","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41398-019-0673-5","article-title":"Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis","volume":"9","author":"Astill Wright","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1795","doi-asserted-by":"crossref","first-page":"113213","DOI":"10.1016\/j.psychres.2020.113213","article-title":"The impact of the COVID-19 pandemic on patients with OCD: effects of contamination symptoms and remission state before the quarantine in a preliminary naturalistic study","volume":"291","author":"Davide","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1800","doi-asserted-by":"crossref","first-page":"112966","DOI":"10.1016\/j.psychres.2020.112966","article-title":"The other side of COVID-19: impact on obsessive compulsive disorder (OCD) and hoarding","volume":"288","author":"Banerjee","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1805","doi-asserted-by":"crossref","first-page":"152174","DOI":"10.1016\/j.comppsych.2020.152174","volume":"100","author":"Fineberg","year":"2020","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1810","doi-asserted-by":"crossref","first-page":"103530","DOI":"10.1016\/j.resp.2020.103530","article-title":"COVID-19 and its psychological consequences: beware of the respiratory subtype of panic disorder","volume":"282","author":"Javelot","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1815","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/bdi.12947","article-title":"Bipolar disorder, COVID-19, and the risk of relaps","volume":"22","author":"Rajkumar","year":"2020","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1820","first-page":"20l02641","article-title":"Mania precipitated by COVID-19 pandemic-related stress","volume":"22","author":"Uvais","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib1825","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jad.2020.08.031","article-title":"First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder","volume":"277","author":"Lu","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib1830","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jad.2010.09.029","article-title":"Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts","volume":"130","author":"Okusaga","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib1835","series-title":"NICE","year":"2014"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1840","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar Disord"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1845","first-page":"e8384","article-title":"Lithium toxicity in two coronavirus disease 2019 (COVID-19) patients","volume":"12","author":"Suwanwongse","year":"2020","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1850","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2215-0366(20)30171-1","article-title":"COVID-19 suicide prevention research collaboration, suicide risk and prevention during the COVID-19 pandemic","volume":"7","author":"Gunnell","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1855","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2215-0366(20)30141-3","article-title":"COVID-19, unemployment, and suicide","volume":"7","author":"Kawohl","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1860","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2215-0366(20)30142-5","article-title":"Suicide prevention during the COVID-19 outbreak","volume":"7","author":"Klomek","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1865","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.psym.2020.05.022","article-title":"Command suicidal hallucination as initial presentation of coronavirus disease 2019 (COVID-19): a case report","volume":"61","author":"Mirza","year":"2020","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1870","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/1516-4446-2020-1210","article-title":"Individuals with untreated psychiatric disorders and suicide in the COVID-19 era","volume":"43","author":"Sher","year":"2020","journal-title":"Braz J Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1875","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2020.21","article-title":"Are COVID-19 survivors at increased risk for suicide?","volume":"32","author":"Sher","year":"2020","journal-title":"Acta Neuropsychiatr"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1880","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1017\/S1041610220000770","article-title":"COVID-19: the implications for suicide in older adults","volume":"32","author":"Wand","year":"2020","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1885","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4088\/JCP.08m04943","article-title":"Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study","volume":"70","author":"Valuck","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1890","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: a matched case-control study","volume":"19","author":"Cato","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1895","first-page":"79","article-title":"Suicidality and side effects of antidepressants and antipsychotics","volume":"22","author":"Mihanovi\u0107","year":"2010","journal-title":"Psychiatr Danub"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib1900","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/wps.20460","article-title":"Antidepressants and suicide risk in depression","volume":"16","author":"Courtet","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib1905","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000434747","article-title":"The contributions of lithium and clozapine for the prophylaxis and treatment of suicidal behavior. Kaschka WP, Rujescu D (eds): biological aspects of suicidal behavior","volume":"30","author":"M\u00fcller-Oerlinghausen","year":"2016","journal-title":"Adv Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1910","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1915","doi-asserted-by":"crossref","first-page":"e13052","DOI":"10.1111\/jsr.13052","article-title":"Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I academy","volume":"29","author":"Altena","year":"2020","journal-title":"J Sleep Res"},{"key":"10.1016\/j.encep.2021.08.002_bib1920","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","article-title":"Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection","volume":"88","author":"Liguori","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1925","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.3390\/diseases8040044","article-title":"Can melatonin be a potential \u201cSilver Bullet\u201d in treating COVID-19 patients?","volume":"8","author":"Cardinali","year":"2020","journal-title":"Diseases"},{"key":"10.1016\/j.encep.2021.08.002_bib1930","first-page":"1","article-title":"Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration","volume":"26","author":"Cardinali","year":"2020","journal-title":"Sleep Vigil"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1935","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S2352-4642(20)30110-3","article-title":"ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group","volume":"4","author":"Cortese","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1940","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S2352-4642(20)30144-9","article-title":"Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group","volume":"4","author":"Cortese","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1945","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.alcohol.2007.06.003","article-title":"Alcohol and airways function in health and disease","volume":"41","author":"Sisson","year":"2007","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib1950","doi-asserted-by":"crossref","first-page":"e022344","DOI":"10.1136\/bmjopen-2018-022344","article-title":"Alcohol and the risk of pneumonia: a systematic review and meta-analysis","volume":"8","author":"Simou","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib1955","first-page":"12","article-title":"Drug interactions with tobacco smoke: Implications for patient care. Savvy psychopharmacology","volume":"12","author":"Fankhauser","year":"2013","journal-title":"Curr Psychiatry"},{"issue":"11","key":"10.1016\/j.encep.2021.08.002_bib1960","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s40262-016-0400-9","article-title":"Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products","volume":"55","author":"Anderson","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib1965","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ps.55.5.491","article-title":"Atypical antipsychotic dosing: the effect of smoking and caffeine","volume":"55","author":"de Leon","year":"2004","journal-title":"Psychiatr Serv"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib1970","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1345\/aph.1M398","article-title":"Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment","volume":"44","author":"Lowe","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib1975","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","article-title":"The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis","volume":"18","author":"Koonrungsesomboon","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.encep.2021.08.002_bib1980","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/B978-0-444-62619-6.00031-8","article-title":"Alcohol-medical drug interactions","volume":"125","author":"Johnson","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.encep.2021.08.002_bib1985","doi-asserted-by":"crossref","first-page":"584462","DOI":"10.3389\/fpsyt.2020.584462","article-title":"Consequences of COVID-19 lockdown on the misuse and marketing of addictive substances and new psychoactive substances","volume":"11","author":"Di Trana","year":"2020","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bib1990","first-page":"639","article-title":"Recommendations about the use of psychotropic medications during the COVID-19 pandemic","volume":"33","author":"Andrade","year":"2020","journal-title":"Acta Med Port"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib1995","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00115-020-00939-4","article-title":"Psychopharmacotherapy during the COVID-19 pandemic","volume":"91","author":"Seifert","year":"2020","journal-title":"Nervenarzt"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib2000","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1192\/bjp.2020.92","article-title":"Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic","volume":"217","author":"Luykx","year":"2020","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib2005","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.87a.ccc016","article-title":"Treating acute anxiety in patients with COVID-19","author":"Khawam","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.encep.2021.08.002_bib2010","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jad.2020.05.149","article-title":"COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry","volume":"274","author":"Anmella","year":"2020","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib2015","first-page":"20com02677","article-title":"Ritonavir\/lopinavir and its potential interactions with psychiatric medications: a COVID-19 perspective","volume":"22","author":"Mansuri","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib2020","first-page":"20com02664","article-title":"Remdesivir and potential interactions with psychotropic medications: a COVID-19 perspective","volume":"22","author":"Mansuri","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib2025","first-page":"185","article-title":"Drug interactions of psychiatric and COVID-19 medications","volume":"11","author":"Mohebbi","year":"2020","journal-title":"Basic Clin Neurosci"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib2030","first-page":"20com02703","article-title":"Opioid use disorder treatment and potential interactions with novel COVID-19 medications: a clinical perspective","volume":"22","author":"Mansuri","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib2035","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.seizure.2020.07.005","article-title":"COVID-19 & antiepileptic drugs: should we pay attention?","volume":"80","author":"F\u0131rat","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.encep.2021.08.002_bib2040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2020.07.015","article-title":"Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?","volume":"223","author":"Nobile","year":"2020","journal-title":"Schizophr Res"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib2045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2215-0366(20)30421-1","article-title":"Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study","volume":"7","author":"Lee","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41419-020-02842-x","article-title":"On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2","volume":"11","author":"Sauvat","year":"2020","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2055","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41401-020-00556-6","article-title":"Identification of SARS-CoV-2 entry inhibitors among already approved drugs","volume":"42","author":"Yang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"21","key":"10.1016\/j.encep.2021.08.002_bib2060","doi-asserted-by":"crossref","first-page":"e01218","DOI":"10.1128\/JVI.01218-20","article-title":"Broad anti-coronavirus activity of food and drug administration-approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo","volume":"94","author":"Weston","year":"2020","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2065","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"10.1016\/j.encep.2021.08.002_bib2070","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib2075","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.7150\/ijms.47836","article-title":"Advances and challenges in the prevention and treatment of COVID-19","volume":"17","author":"Han","year":"2020","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib2080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/ijmm.2020.4608","article-title":"Comprehensive analysis of drugs to treat SARS-CoV-2 infection: mechanistic insights into current COVID-19 therapies (review)","volume":"46","author":"Nitulescu","year":"2020","journal-title":"Int J Mol Med"},{"issue":"6","key":"10.1016\/j.encep.2021.08.002_bib2085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/JCP.0000000000001310","article-title":"Psychosis treatment during COVID-19 pandemic and the potential role of phenothiazines: a call for research studies","volume":"40","author":"Ruiz de Pell\u00f3n Santamar\u00eda","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib2090","doi-asserted-by":"crossref","first-page":"110011","DOI":"10.1016\/j.mehy.2020.110011","article-title":"Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19","volume":"144","author":"Sathyamoorthy","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.encep.2021.08.002_bib2095","doi-asserted-by":"crossref","first-page":"173553","DOI":"10.1016\/j.ejphar.2020.173553","article-title":"Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review","volume":"887","author":"Otr\u0119ba","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib2100","doi-asserted-by":"crossref","first-page":"111997","DOI":"10.1016\/j.jphotobiol.2020.111997","article-title":"Laser irradiated phenothiazines: new potential treatment for COVID-19 explored by molecular docking","volume":"211","author":"Udrea","year":"2020","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.encep.2021.08.002_bib2105","doi-asserted-by":"crossref","first-page":"109798","DOI":"10.1016\/j.mehy.2020.109798","article-title":"Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia","volume":"142","author":"Bou Khalil","year":"2020","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib2110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40345-020-00191-4","article-title":"International Group for The Study of Lithium Treated Patients (IGSLi). Lithium's antiviral effects: a potential drug for CoViD-19 disease?","volume":"8","author":"Murru","year":"2020","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib2115","first-page":"93","article-title":"Lithium and coronaviral infections. A scoping review","volume":"9","author":"Nowak","year":"2020","journal-title":"F1000Res"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib2120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ddr.21701","article-title":"Lithium as a candidate treatment for COVID-19: promises and pitfalls","volume":"81","author":"Rajkumar","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.encep.2021.08.002_bib2125","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3389\/fimmu.2020.01638","article-title":"GSK-3 inhibition as a therapeutic approach against SARs-CoV-2: dual benefit of inhibiting viral replication while potentiating the immune response","volume":"11","author":"Rudd","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib2130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bdi.12975","article-title":"A tale of (glycogen synthase kinase) three: lithium, the kidney and coronavirus disease 19","volume":"23","author":"Theotonio Dos Santos","year":"2021","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.encep.2021.08.002_bib2135","doi-asserted-by":"crossref","first-page":"557629","DOI":"10.3389\/fphar.2020.557629","article-title":"Does lithium deserve a place in the treatment against COVID-19? A preliminary observational study in six patients, case report","volume":"11","author":"Spuch","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.encep.2021.08.002_bib2140","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.18632\/aging.103449","article-title":"Microdose lithium reduces cellular senescence in human astrocytes\u00a0\u2013\u00a0a potential pharmacotherapy for COVID-19?","volume":"12","author":"Viel","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2145","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.xcrm.2020.100142","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.encep.2021.08.002_bib2150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11481-020-09939-2","article-title":"Clomipramine could be useful in preventing neurological complications of SARS-CoV-2 infection","volume":"15","author":"Nobile","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"17","key":"10.1016\/j.encep.2021.08.002_bib2155","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1111\/febs.15369","article-title":"Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing","volume":"287","author":"Glebov","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.encep.2021.08.002_bib2160","doi-asserted-by":"crossref","first-page":"110140","DOI":"10.1016\/j.mehy.2020.110140","article-title":"The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients","volume":"144","author":"Hamed","year":"2020","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib2165","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/22221751.2020.1829082","article-title":"Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine","volume":"9","author":"Schloer","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"22","key":"10.1016\/j.encep.2021.08.002_bib2170","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs. placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.encep.2021.08.002_bib2175","doi-asserted-by":"crossref","first-page":"109774","DOI":"10.1016\/j.mehy.2020.109774","article-title":"Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)","volume":"141","author":"Altschuler","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.encep.2021.08.002_bib2180","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.encep.2021.08.002_bib2185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2020.04.028","article-title":"A longitudinal study on the mental health of general population during the COVID-19 epidemic in China","volume":"87","author":"Wang","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.encep.2021.08.002_bib2190","doi-asserted-by":"crossref","first-page":"155100","DOI":"10.1016\/j.cyto.2020.155100","article-title":"Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis","volume":"131","author":"Almeida","year":"2020","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib2195","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib2200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"Pt C","key":"10.1016\/j.encep.2021.08.002_bib2205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers\u00a0\u2013\u00a0A meta-analysis","volume":"80","author":"Wi\u0119d\u0142ocha","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib2210","doi-asserted-by":"crossref","first-page":"582310","DOI":"10.3389\/fphar.2020.582310","article-title":"Repurposing sigma-1 receptor ligands for COVID-19 therapy?","volume":"11","author":"Vela","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib2215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jocn.2020.08.014","article-title":"Reissuing the sigma receptors for SARS-CoV-2","volume":"80","author":"Yesilkaya","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.encep.2021.08.002_bib2220","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2147\/TCRM.S262936","article-title":"The current recommended drugs and strategies for the treatment of coronavirus disease (COVID-19)","volume":"16","author":"Sheikhpour","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"10.1016\/j.encep.2021.08.002_bib2225","doi-asserted-by":"crossref","first-page":"e9628","DOI":"10.15252\/msb.20209628","article-title":"In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression","volume":"16","author":"Sinha","year":"2020","journal-title":"Mol Syst Biol"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib2230","first-page":"1","article-title":"Inverse association between serotonin 2A receptor antagonist medication use and mortality in severe COVID-19 infection","volume":"4","author":"Zimering","year":"2020","journal-title":"Endocrinol Diabetes Metab J"},{"key":"10.1016\/j.encep.2021.08.002_bib2235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.toxrep.2020.04.012","article-title":"Editorial: nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system","volume":"7","author":"Farsalinos","year":"2020","journal-title":"Toxicol Rep"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2240","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s11739-020-02473-2","article-title":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?","volume":"15","author":"Takagi","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.encep.2021.08.002_bib2245","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320935765","article-title":"Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Farsalinos","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib2250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11739-020-02355-7","article-title":"Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?","volume":"15","author":"Farsalinos","year":"2020","journal-title":"Intern Emerg Med"},{"issue":"22","key":"10.1016\/j.encep.2021.08.002_bib2255","first-page":"22425","article-title":"In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib2260","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/15622975.2020.1814408","article-title":"Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?","volume":"22","author":"Buemann","year":"2020","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib2265","doi-asserted-by":"crossref","first-page":"110329","DOI":"10.1016\/j.mehy.2020.110329","article-title":"Oxytocin is a direct COVID-19 antiviral","volume":"145","author":"Diep","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.encep.2021.08.002_bib2270","article-title":"Oxytocin as a potential adjuvant against COVID-19 infection","author":"Thakur","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.encep.2021.08.002_bib2275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-7091-1368-4_9","article-title":"Functional inhibitors of acid sphingomyelinase (FIASMAs)","volume":"215","author":"Kornhuber","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.encep.2021.08.002_bib2280","doi-asserted-by":"crossref","first-page":"113220","DOI":"10.1016\/j.psychres.2020.113220","article-title":"Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: a mechanistic hypothesis","volume":"291","author":"Vaugeois","year":"2020","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.encep.2021.08.002_bib2285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000315101","article-title":"Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications","volume":"26","author":"Kornhuber","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib2290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62\u2008354 COVID-19 cases in the USA","volume":"8","author":"Taquet","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2021.08.002_bib2295","doi-asserted-by":"crossref","first-page":"e2023282","DOI":"10.1001\/jamanetworkopen.2020.23282","article-title":"Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) infection","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.encep.2021.08.002_bib2300","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jagp.2020.09.016","article-title":"Risk of mortality in elderly coronavirus disease 2019 patients with mental health disorders: a nationwide retrospective study in South Korea","volume":"28","author":"Lee","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib2305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3851\/IMP3368","article-title":"Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system","volume":"25","author":"Jarvis","year":"2020","journal-title":"Antivir Ther"},{"key":"10.1016\/j.encep.2021.08.002_bib2310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.encep.2021.08.002_bib2315","doi-asserted-by":"crossref","first-page":"V","DOI":"10.1590\/0100-3984.2020.53.2e1","article-title":"Information about the new coronavirus disease (COVID-19)","volume":"53","author":"Lima","year":"2020","journal-title":"Radiol Bras"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib2320","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1096\/fj.202000502","article-title":"Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib2325","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11739-020-02361-9","article-title":"COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine","volume":"15","author":"Polosa","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.encep.2021.08.002_bib2330","doi-asserted-by":"crossref","first-page":"118105","DOI":"10.1016\/j.lfs.2020.118105","article-title":"An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic","volume":"257","author":"Jamwal","year":"2020","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.encep.2021.08.002_bib2335","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0004867420961472","article-title":"Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19","volume":"55","author":"Pantelis","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib2340","first-page":"1917","article-title":"The first psychiatric pandemic: encephalitis lethargica","volume":"110420","author":"Shorter","year":"2020","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.encep.2021.08.002_bibe0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0706743720934997","article-title":"Psychiatry and COVID-19: the role of chlorpromazine","volume":"65","author":"Stip","year":"2020","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2021.08.002_bib2350","first-page":"592737","article-title":"Drug repurposing screen for compounds inhibiting the cytopathic effect of SARS-CoV-2","volume":"11","author":"Chen","year":"2020","journal-title":"bioRxiv"},{"issue":"28","key":"10.1016\/j.encep.2021.08.002_bib2355","doi-asserted-by":"crossref","first-page":"26256","DOI":"10.1074\/jbc.M500835200","article-title":"Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms","volume":"280","author":"Grassm\u00e9","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.encep.2021.08.002_bib2360","doi-asserted-by":"crossref","first-page":"109891","DOI":"10.1016\/j.mehy.2020.109891","article-title":"Immunopharmacological management of COVID-19: potential therapeutic role of valproic acid","volume":"143","author":"Unal","year":"2020","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.encep.2021.08.002_bib2365","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaneurol.2014.4625","article-title":"Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis","volume":"72","author":"Tyler","year":"2015","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.encep.2021.08.002_bib2370","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine is a potent inhibitor of coxsackievirus replication","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.encep.2021.08.002_bib2375","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.therap.2016.12.010","article-title":"The anticholinergic impregnation scale: towards the elaboration of a scale adapted to prescriptions in French psychiatric settings","volume":"72","author":"Briet","year":"2017","journal-title":"Therapie"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621001718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621001718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T01:44:19Z","timestamp":1762134259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700621001718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":276,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0013700621001718"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2021.08.002","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropics and COVID-19: An analysis of safety and prophylaxis","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}